98 related articles for article (PubMed ID: 17635078)
1. Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome.
Niculescu LS; Fruchart-Najib J; Fruchart JC; Sima A
Clin Chem Lab Med; 2007; 45(9):1133-9. PubMed ID: 17635078
[TBL] [Abstract][Full Text] [Related]
2. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
3. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
Zaki M; Amr K
Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
[TBL] [Abstract][Full Text] [Related]
5. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
6. Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; de Bakker PI; Asselbergs FW; Spiering W; Visseren FL;
PLoS One; 2014; 9(6):e101082. PubMed ID: 24979386
[TBL] [Abstract][Full Text] [Related]
7. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
8. [Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease].
Oliveira Sousa M; Alía P; Pintó X
Med Clin (Barc); 2008 May; 130(20):787-93. PubMed ID: 18579034
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change.
Hubacek JA; Bohuslavova R; Skodova Z; Pitha J; Bobkova D; Poledne R
Clin Chem Lab Med; 2007; 45(3):316-20. PubMed ID: 17378725
[TBL] [Abstract][Full Text] [Related]
11. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
Eichenbaum-Voline S; Olivier M; Jones EL; Naoumova RP; Jones B; Gau B; Patel HN; Seed M; Betteridge DJ; Galton DJ; Rubin EM; Scott J; Shoulders CC; Pennacchio LA
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):167-74. PubMed ID: 14551155
[TBL] [Abstract][Full Text] [Related]
12. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E polymorphism--a risk factor for metabolic syndrome.
Sima A; Iordan A; Stancu C
Clin Chem Lab Med; 2007; 45(9):1149-53. PubMed ID: 17848120
[TBL] [Abstract][Full Text] [Related]
14. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.
Lai CQ; Demissie S; Cupples LA; Zhu Y; Adiconis X; Parnell LD; Corella D; Ordovas JM
J Lipid Res; 2004 Nov; 45(11):2096-105. PubMed ID: 15342688
[TBL] [Abstract][Full Text] [Related]
15. Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population.
Chien KL; Chen MF; Hsu HC; Su TC; Chang WT; Lee CM; Lee YT
Clin Chim Acta; 2008 Feb; 388(1-2):78-83. PubMed ID: 17964293
[TBL] [Abstract][Full Text] [Related]
16. The role of apolipoprotein A5 in obesity and the metabolic syndrome.
Zheng XY; Zhao SP; Yan H
Biol Rev Camb Philos Soc; 2013 May; 88(2):490-8. PubMed ID: 23279260
[TBL] [Abstract][Full Text] [Related]
17. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study.
Corella D; Lai CQ; Demissie S; Cupples LA; Manning AK; Tucker KL; Ordovas JM
J Mol Med (Berl); 2007 Feb; 85(2):119-28. PubMed ID: 17211608
[TBL] [Abstract][Full Text] [Related]
18. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
19. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
[TBL] [Abstract][Full Text] [Related]
20. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides.
Dallongeville J; Cottel D; Wagner A; Ducimetière P; Ruidavets JB; Arveiler D; Bingham A; Ferrières J; Amouyel P; Meirhaeghe A
BMC Med Genet; 2008 Sep; 9():84. PubMed ID: 18789138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]